Apimeds Pharmaceuticals US Launches Fully Insured Blockchain Network

Apimeds Pharmaceuticals US, Inc., through its wholly owned subsidiary MindWave Innovations Inc., announced plans to launch MindChain, a fully insured blockchain network compatible with the Ethereum Virtual Machine (EVM). This Layer 2 network will serve as a secondary system built on top of Ethereum, handling transactions and computations off the main ledger to make the network faster and cheaper. MindChain's key features include its ability to process payments and transfers in under 1-2 seconds.

The launch of MindChain is scheduled for October 2026, with a planned testnet period from August to September 2026. During this time, the community and developers will have the opportunity to onboard and prepare for the mainnet launch. The company also announced that its NILA token will become available on Webot, a licensed U.S. crypto exchange, starting August 3, 2026.

Upon the launch of MindChain, NILA will serve as the network's native gas and staking token, providing users with utility and incentives to participate in the network. The company plans to run a dedicated network for its subsidiary, giving NILA native utility pending the October mainnet. Apimeds Pharmaceuticals US has previously experienced significant price movements following corporate and regulatory news announcements.